Methylglyoxal BIS (guanylhydrazone) and alpha-difluoromethylornithine-induced polyamine deprivation in psoriatic lesions.
D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D004305:Dose-Response Relationship, Drug; D000518:Eflornithine; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D007271:Injections, Intradermal; D008935:Mitoguazone / Q000008:administration & dosage / Q000494:pharmacology*; D009952:Ornithine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines / Q000378:metabolism*; D011565:Psoriasis / Q000378:metabolism*; D011700:Putrescine / Q000032:analysis; D012867:Skin / Q000187:drug effects; D013095:Spermidine / Q000032:analysis; D013096:Spermine / Q000032:analysis
D006146:Guanidines; D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines; D013096:Spermine; D009952:Ornithine; D002262:Carboxy-Lyases; D008935:Mitoguazone; D013095:Spermidine; D011700:Putrescine; D000518:Eflornithine